Trials / Completed
CompletedNCT01916291
Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 189 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Dinoprostone(propess) is commonly used for induction of labor in the pregnant women who has intact membrane after 38weeks of gestational age. The investigators study safety and efficacy of dinoprostone in the pregnant women with premature rupture of membrane or GA\<38weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propess insertion group |
Timeline
- Start date
- 2013-08-25
- Primary completion
- 2018-08-14
- Completion
- 2019-04-04
- First posted
- 2013-08-05
- Last updated
- 2020-03-24
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01916291. Inclusion in this directory is not an endorsement.